

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.95211966 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.95211966 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.47664528 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.47664528 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.12924611 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67563536 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.41767013 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.41767013 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.41767013 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.38661109 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36184746 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.17706231 |
| 13 | urea cycle (GO:0000050) | 5.17091248 |
| 14 | urea metabolic process (GO:0019627) | 5.17091248 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.09901260 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.07905829 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.94252434 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.92027788 |
| 19 | protein carboxylation (GO:0018214) | 4.91905047 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.91905047 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.91698947 |
| 22 | regulation of protein activation cascade (GO:2000257) | 4.88901396 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.77936473 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.68809581 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.62846578 |
| 26 | regulation of complement activation (GO:0030449) | 4.57310108 |
| 27 | bile acid metabolic process (GO:0008206) | 4.49675300 |
| 28 | cysteine metabolic process (GO:0006534) | 4.40174459 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.32048347 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.30687646 |
| 31 | phospholipid efflux (GO:0033700) | 4.29557619 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.29319554 |
| 33 | lysine catabolic process (GO:0006554) | 4.28491244 |
| 34 | lysine metabolic process (GO:0006553) | 4.28491244 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 4.28324940 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.27965276 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.27598505 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 4.26986167 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.20048753 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.20048753 |
| 41 | nucleobase catabolic process (GO:0046113) | 4.18998550 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.17091379 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 4.16940196 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.16940196 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.09221583 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.08181826 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.06534666 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.00843324 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.00843324 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.00843324 |
| 51 | coenzyme catabolic process (GO:0009109) | 3.98669486 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 3.97025211 |
| 53 | glutamate metabolic process (GO:0006536) | 3.96813850 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 3.95984097 |
| 55 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95228111 |
| 56 | cholesterol efflux (GO:0033344) | 3.94353137 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.91444309 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 3.90304463 |
| 59 | drug catabolic process (GO:0042737) | 3.90053768 |
| 60 | arginine metabolic process (GO:0006525) | 3.84350450 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.82141001 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.78919305 |
| 63 | neuron cell-cell adhesion (GO:0007158) | 3.74696506 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 3.69460589 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 3.68398639 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.65191076 |
| 67 | ketone body metabolic process (GO:1902224) | 3.64158081 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63427745 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61670572 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.57340537 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.56755928 |
| 72 | cellular glucuronidation (GO:0052695) | 3.56566068 |
| 73 | complement activation, classical pathway (GO:0006958) | 3.55468506 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.55064336 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.53236443 |
| 76 | gamma-aminobutyric acid transport (GO:0015812) | 3.52636189 |
| 77 | complement activation (GO:0006956) | 3.50572851 |
| 78 | postsynaptic membrane organization (GO:0001941) | 3.50296210 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.49378255 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 3.48812537 |
| 81 | amine catabolic process (GO:0009310) | 3.48812537 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.48308620 |
| 83 | ethanol oxidation (GO:0006069) | 3.47004494 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.46353294 |
| 85 | fibrinolysis (GO:0042730) | 3.46251874 |
| 86 | negative regulation of protein activation cascade (GO:2000258) | 3.35435642 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.34525976 |
| 88 | glutamate receptor signaling pathway (GO:0007215) | 3.34211643 |
| 89 | protein activation cascade (GO:0072376) | 3.32839189 |
| 90 | sterol homeostasis (GO:0055092) | 3.30793874 |
| 91 | protein-lipid complex assembly (GO:0065005) | 3.28423699 |
| 92 | synaptic transmission, glutamatergic (GO:0035249) | 3.28149379 |
| 93 | presynaptic membrane assembly (GO:0097105) | 3.27921828 |
| 94 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.27128126 |
| 95 | cofactor catabolic process (GO:0051187) | 3.25664551 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.24186673 |
| 97 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.21872783 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.21417491 |
| 99 | presynaptic membrane organization (GO:0097090) | 3.21016865 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.20672190 |
| 101 | glycine metabolic process (GO:0006544) | 3.19238514 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 3.18775930 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.15830854 |
| 104 | organic acid catabolic process (GO:0016054) | 3.15830854 |
| 105 | lipoprotein metabolic process (GO:0042157) | 3.14157070 |
| 106 | epoxygenase P450 pathway (GO:0019373) | 3.13379025 |
| 107 | vocalization behavior (GO:0071625) | 3.13140980 |
| 108 | aspartate family amino acid catabolic process (GO:0009068) | 3.12465640 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.11974421 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.11974421 |
| 111 | cerebellar granule cell differentiation (GO:0021707) | 3.10909324 |
| 112 | plasma lipoprotein particle organization (GO:0071827) | 3.10781376 |
| 113 | neuronal action potential propagation (GO:0019227) | 2.99295020 |
| 114 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.97211056 |
| 115 | synaptic vesicle maturation (GO:0016188) | 2.96078988 |
| 116 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.90894608 |
| 117 | neuron-neuron synaptic transmission (GO:0007270) | 2.90144844 |
| 118 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.89019448 |
| 119 | nerve growth factor signaling pathway (GO:0038180) | 2.88523760 |
| 120 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.88277858 |
| 121 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.82939907 |
| 122 | synaptic vesicle exocytosis (GO:0016079) | 2.80446826 |
| 123 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.80250463 |
| 124 | synapse assembly (GO:0007416) | 2.79507392 |
| 125 | neuron recognition (GO:0008038) | 2.78689462 |
| 126 | axonal fasciculation (GO:0007413) | 2.78403396 |
| 127 | regulation of synapse structural plasticity (GO:0051823) | 2.75836828 |
| 128 | dendritic spine morphogenesis (GO:0060997) | 2.75827751 |
| 129 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.74585729 |
| 130 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.71892211 |
| 131 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70746016 |
| 132 | neurotransmitter secretion (GO:0007269) | 2.69138213 |
| 133 | regulation of synaptic vesicle transport (GO:1902803) | 2.68314310 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.67559282 |
| 135 | membrane depolarization during action potential (GO:0086010) | 2.64604552 |
| 136 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.61175539 |
| 137 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58565919 |
| 138 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.57076393 |
| 139 | startle response (GO:0001964) | 2.56671566 |
| 140 | protein localization to synapse (GO:0035418) | 2.55970425 |
| 141 | positive regulation of amino acid transport (GO:0051957) | 2.55603241 |
| 142 | neurofilament cytoskeleton organization (GO:0060052) | 2.55456805 |
| 143 | dendrite morphogenesis (GO:0048813) | 2.52603797 |
| 144 | exploration behavior (GO:0035640) | 2.45367002 |
| 145 | C4-dicarboxylate transport (GO:0015740) | 2.44165032 |
| 146 | locomotory exploration behavior (GO:0035641) | 2.44124066 |
| 147 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.42919962 |
| 148 | auditory behavior (GO:0031223) | 2.41376490 |
| 149 | detection of calcium ion (GO:0005513) | 2.38985950 |
| 150 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36907385 |
| 151 | regulation of neuron projection regeneration (GO:0070570) | 2.36492862 |
| 152 | regulation of axon regeneration (GO:0048679) | 2.36492862 |
| 153 | cell differentiation in hindbrain (GO:0021533) | 2.34025327 |
| 154 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.28869675 |
| 155 | transmission of nerve impulse (GO:0019226) | 2.26432930 |
| 156 | negative regulation of neurotransmitter transport (GO:0051589) | 2.25364855 |
| 157 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.24809294 |
| 158 | activated T cell proliferation (GO:0050798) | 2.24128394 |
| 159 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.22558785 |
| 160 | negative regulation of synaptic transmission (GO:0050805) | 2.20551930 |
| 161 | neuronal action potential (GO:0019228) | 2.20440367 |
| 162 | regulation of postsynaptic membrane potential (GO:0060078) | 2.20019280 |
| 163 | short-term memory (GO:0007614) | 2.19489413 |
| 164 | establishment of mitochondrion localization (GO:0051654) | 2.18169389 |
| 165 | regulation of neurotransmitter levels (GO:0001505) | 2.18099954 |
| 166 | membrane depolarization (GO:0051899) | 2.17976520 |
| 167 | cellular sodium ion homeostasis (GO:0006883) | 2.17540082 |
| 168 | synapse organization (GO:0050808) | 2.16740623 |
| 169 | behavioral response to nicotine (GO:0035095) | 2.15582653 |
| 170 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.14273597 |
| 171 | mechanosensory behavior (GO:0007638) | 2.14150976 |
| 172 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.13202995 |
| 173 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.11611589 |
| 174 | regulation of membrane repolarization (GO:0060306) | 2.10598127 |
| 175 | positive regulation of synapse maturation (GO:0090129) | 2.08500679 |
| 176 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.08199888 |
| 177 | long-term synaptic potentiation (GO:0060291) | 2.08133167 |
| 178 | regulation of dendritic spine development (GO:0060998) | 2.07968684 |
| 179 | negative regulation of dendrite development (GO:2000171) | 2.07523682 |
| 180 | adult walking behavior (GO:0007628) | 2.07191858 |
| 181 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.06257874 |
| 182 | regulation of neurotransmitter secretion (GO:0046928) | 2.06254119 |
| 183 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.05864766 |
| 184 | glutamate secretion (GO:0014047) | 2.05248104 |
| 185 | regulation of synapse maturation (GO:0090128) | 2.04218575 |
| 186 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.04113233 |
| 187 | negative regulation of B cell mediated immunity (GO:0002713) | 2.04113233 |
| 188 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.03759797 |
| 189 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.03632668 |
| 190 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.02818205 |
| 191 | regulation of sarcomere organization (GO:0060297) | 2.02101381 |
| 192 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.01683653 |
| 193 | positive regulation of membrane potential (GO:0045838) | 2.00486552 |
| 194 | neurotransmitter transport (GO:0006836) | 1.97394223 |
| 195 | neurotransmitter metabolic process (GO:0042133) | 1.97177249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.73374866 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38861337 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.42445561 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.20458235 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.72098841 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.40634851 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09845824 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57579283 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43267085 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.30857448 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.88997169 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16526243 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06313605 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.04474107 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03438970 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.95942850 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.92768788 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87167072 |
| 19 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86185519 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82205520 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81079502 |
| 22 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.78564451 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72196315 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71422653 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67788672 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66529565 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63365518 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62156455 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59842330 |
| 30 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58510535 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55579351 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53739342 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51835409 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48664695 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47341992 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45116462 |
| 37 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44694036 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42508274 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41405440 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41313785 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41084880 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40532277 |
| 43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38300380 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33634352 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32785718 |
| 46 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.31317260 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30276320 |
| 48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30276320 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30049916 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28223537 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.27317254 |
| 52 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.27130583 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26260179 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23656286 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23622231 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23447345 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23253701 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22569870 |
| 59 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21441951 |
| 60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21292460 |
| 61 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20392656 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20380585 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19609297 |
| 64 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19119720 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19119720 |
| 66 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18620039 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18381467 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18046053 |
| 69 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17128820 |
| 70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16757817 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14686435 |
| 72 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.13709654 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12346322 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12341240 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11282932 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10737243 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10254620 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08054291 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08042267 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07928815 |
| 81 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07552112 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07523758 |
| 83 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06331298 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05194976 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03960804 |
| 86 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03467292 |
| 87 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02659218 |
| 88 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02633860 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02363583 |
| 90 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01319421 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00854674 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00441978 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98683807 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98429947 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98182620 |
| 96 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98032638 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97588771 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97224766 |
| 99 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97070984 |
| 100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96476476 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95217466 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95031597 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94244394 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93666485 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92496827 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92313279 |
| 107 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92289539 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91974918 |
| 109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91046132 |
| 110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90765158 |
| 111 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90681387 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90471298 |
| 113 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90353507 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90224269 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89928977 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89027107 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88814760 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88701079 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84260912 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83806089 |
| 121 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83576225 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81341503 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81028463 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79423113 |
| 125 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.79242589 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.79030477 |
| 127 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78958245 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78613186 |
| 129 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78582708 |
| 130 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78425271 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78267450 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.76577909 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76277169 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74839750 |
| 135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74134288 |
| 136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74006630 |
| 137 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73936569 |
| 138 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73936569 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.73121419 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72860623 |
| 141 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71869945 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71026625 |
| 143 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.69929653 |
| 144 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.69863101 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69668517 |
| 146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69642910 |
| 147 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69642910 |
| 148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.68329801 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68133088 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.66846863 |
| 151 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.66667505 |
| 152 | GATA1_22025678_ChIP-Seq_K562_Human | 0.66015530 |
| 153 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.65464092 |
| 154 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.65453218 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.65440600 |
| 156 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.65229303 |
| 157 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65009820 |
| 158 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.64191373 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.63903905 |
| 160 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.63639703 |
| 161 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.63408231 |
| 162 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.62367758 |
| 163 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.62112607 |
| 164 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.61436235 |
| 165 | AR_19668381_ChIP-Seq_PC3_Human | 0.60793119 |
| 166 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.60688566 |
| 167 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.60101076 |
| 168 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.59971815 |
| 169 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59616478 |
| 170 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.58838456 |
| 171 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.58834080 |
| 172 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.58508982 |
| 173 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.58434397 |
| 174 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.58417509 |
| 175 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58305041 |
| 176 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.58250605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.74250970 |
| 2 | MP0005360_urolithiasis | 7.12786458 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.85190710 |
| 4 | MP0005365_abnormal_bile_salt | 5.72350484 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.75938487 |
| 6 | MP0003252_abnormal_bile_duct | 3.94688524 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.56261282 |
| 8 | MP0005083_abnormal_biliary_tract | 3.38479108 |
| 9 | MP0004270_analgesia | 3.31917553 |
| 10 | MP0003880_abnormal_central_pattern | 3.19614098 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 3.06870174 |
| 12 | MP0009840_abnormal_foam_cell | 3.06198798 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.87988766 |
| 14 | MP0003787_abnormal_imprinting | 2.85945689 |
| 15 | MP0009046_muscle_twitch | 2.75855673 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.69076882 |
| 17 | MP0003195_calcinosis | 2.64953051 |
| 18 | MP0005332_abnormal_amino_acid | 2.48057812 |
| 19 | MP0002272_abnormal_nervous_system | 2.43998100 |
| 20 | MP0003122_maternal_imprinting | 2.36917267 |
| 21 | MP0001984_abnormal_olfaction | 2.35850520 |
| 22 | MP0009745_abnormal_behavioral_response | 2.31637796 |
| 23 | MP0002064_seizures | 2.30601829 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.30212877 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.27696306 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.21665905 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.18285797 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.17950580 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.14769784 |
| 30 | MP0001486_abnormal_startle_reflex | 2.13369622 |
| 31 | MP0005423_abnormal_somatic_nervous | 2.07514978 |
| 32 | MP0000609_abnormal_liver_physiology | 2.06802586 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.95690113 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.95365578 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.91791116 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.90997126 |
| 37 | MP0002736_abnormal_nociception_after | 1.85977959 |
| 38 | MP0003868_abnormal_feces_composition | 1.76761580 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.75784644 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.75686237 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.71934507 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.71664265 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.71355615 |
| 44 | MP0001970_abnormal_pain_threshold | 1.71176882 |
| 45 | MP0004742_abnormal_vestibular_system | 1.69828447 |
| 46 | MP0004142_abnormal_muscle_tone | 1.68946179 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.66642486 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.61389943 |
| 49 | MP0003879_abnormal_hair_cell | 1.61301260 |
| 50 | MP0008569_lethality_at_weaning | 1.59456485 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.58391505 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.55741674 |
| 53 | MP0000604_amyloidosis | 1.52465774 |
| 54 | MP0001188_hyperpigmentation | 1.47432295 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.46663359 |
| 56 | MP0004924_abnormal_behavior | 1.46663359 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.46269348 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.43605817 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39662571 |
| 60 | MP0003690_abnormal_glial_cell | 1.36730461 |
| 61 | MP0002822_catalepsy | 1.31729349 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.28583317 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.28089677 |
| 64 | MP0005670_abnormal_white_adipose | 1.26440369 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.25108698 |
| 66 | MP0005451_abnormal_body_composition | 1.24898428 |
| 67 | MP0004130_abnormal_muscle_cell | 1.22375365 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.21818580 |
| 69 | MP0002184_abnormal_innervation | 1.20571811 |
| 70 | MP0003121_genomic_imprinting | 1.20526809 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.18752438 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.18636190 |
| 73 | MP0003631_nervous_system_phenotype | 1.16753076 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 1.15883558 |
| 75 | MP0002229_neurodegeneration | 1.14334378 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.13099875 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.12103321 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.12089405 |
| 79 | MP0004043_abnormal_pH_regulation | 1.11563400 |
| 80 | MP0003329_amyloid_beta_deposits | 1.10292170 |
| 81 | MP0002102_abnormal_ear_morphology | 1.07082891 |
| 82 | MP0000598_abnormal_liver_morphology | 1.06077892 |
| 83 | MP0002254_reproductive_system_inflammat | 1.05517528 |
| 84 | MP0003303_peritoneal_inflammation | 1.04934695 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.02893361 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.00330558 |
| 87 | MP0003724_increased_susceptibility_to | 1.00141699 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.97450195 |
| 89 | MP0000955_abnormal_spinal_cord | 0.96633392 |
| 90 | MP0004484_altered_response_of | 0.96368065 |
| 91 | MP0009780_abnormal_chondrocyte_physiolo | 0.94972201 |
| 92 | MP0005647_abnormal_sex_gland | 0.94300898 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.93530968 |
| 94 | MP0001764_abnormal_homeostasis | 0.88695685 |
| 95 | MP0003011_delayed_dark_adaptation | 0.87948286 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.87785455 |
| 97 | MP0009763_increased_sensitivity_to | 0.86541426 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.85531295 |
| 99 | MP0005409_darkened_coat_color | 0.82395386 |
| 100 | MP0004085_abnormal_heartbeat | 0.82199922 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.81528913 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.81371087 |
| 103 | MP0005334_abnormal_fat_pad | 0.80196171 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.80022369 |
| 105 | MP0003300_gastrointestinal_ulcer | 0.79480933 |
| 106 | MP0002971_abnormal_brown_adipose | 0.77699463 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.77531026 |
| 108 | MP0002928_abnormal_bile_duct | 0.74754604 |
| 109 | MP0004885_abnormal_endolymph | 0.74208450 |
| 110 | MP0004510_myositis | 0.72106793 |
| 111 | MP0009764_decreased_sensitivity_to | 0.71400719 |
| 112 | MP0001905_abnormal_dopamine_level | 0.71262071 |
| 113 | MP0005187_abnormal_penis_morphology | 0.70357320 |
| 114 | MP0002152_abnormal_brain_morphology | 0.68707599 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.68473281 |
| 116 | MP0001756_abnormal_urination | 0.67109015 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.66431070 |
| 118 | MP0005253_abnormal_eye_physiology | 0.66081325 |
| 119 | MP0005535_abnormal_body_temperature | 0.65701507 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.65333683 |
| 121 | MP0008872_abnormal_physiological_respon | 0.64020176 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.63885967 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.62877499 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.62658306 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.62532978 |
| 126 | MP0001915_intracranial_hemorrhage | 0.60668569 |
| 127 | MP0005408_hypopigmentation | 0.60655499 |
| 128 | MP0005448_abnormal_energy_balance | 0.60328862 |
| 129 | MP0008469_abnormal_protein_level | 0.59206908 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.59031629 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.58949263 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.58300534 |
| 133 | MP0009697_abnormal_copulation | 0.57969464 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.55529799 |
| 135 | MP0001879_abnormal_lymphatic_vessel | 0.55514080 |
| 136 | MP0009672_abnormal_birth_weight | 0.53308348 |
| 137 | * MP0002136_abnormal_kidney_physiology | 0.53194299 |
| 138 | MP0000579_abnormal_nail_morphology | 0.52365117 |
| 139 | MP0000778_abnormal_nervous_system | 0.51996048 |
| 140 | MP0002090_abnormal_vision | 0.51169988 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.50613730 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.50417815 |
| 143 | MP0008874_decreased_physiological_sensi | 0.50250381 |
| 144 | MP0004883_abnormal_blood_vessel | 0.49996090 |
| 145 | MP0009053_abnormal_anal_canal | 0.49988252 |
| 146 | MP0003632_abnormal_nervous_system | 0.49649751 |
| 147 | MP0005636_abnormal_mineral_homeostasis | 0.49507930 |
| 148 | MP0003953_abnormal_hormone_level | 0.47081393 |
| 149 | MP0005266_abnormal_metabolism | 0.45124107 |
| 150 | MP0001881_abnormal_mammary_gland | 0.45016933 |
| 151 | MP0001661_extended_life_span | 0.43566561 |
| 152 | MP0004185_abnormal_adipocyte_glucose | 0.42417811 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.42251136 |
| 154 | MP0002168_other_aberrant_phenotype | 0.42222940 |
| 155 | MP0005166_decreased_susceptibility_to | 0.41069270 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.40495485 |
| 157 | MP0003186_abnormal_redox_activity | 0.40400774 |
| 158 | MP0002909_abnormal_adrenal_gland | 0.39836490 |
| 159 | MP0009115_abnormal_fat_cell | 0.39777930 |
| 160 | MP0003638_abnormal_response/metabolism_ | 0.38687431 |
| 161 | MP0005375_adipose_tissue_phenotype | 0.38633814 |
| 162 | MP0005058_abnormal_lysosome_morphology | 0.38046449 |
| 163 | MP0002970_abnormal_white_adipose | 0.37694133 |
| 164 | MP0002697_abnormal_eye_size | 0.37363394 |
| 165 | MP0000230_abnormal_systemic_arterial | 0.35884445 |
| 166 | MP0003633_abnormal_nervous_system | 0.35537500 |
| 167 | MP0005197_abnormal_uvea_morphology | 0.34920966 |
| 168 | MP0000920_abnormal_myelination | 0.33434376 |
| 169 | MP0002069_abnormal_eating/drinking_beha | 0.33192616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.02500992 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.27963151 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.24895431 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.66433382 |
| 5 | Xanthomatosis (HP:0000991) | 5.59693436 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.24351950 |
| 7 | Complement deficiency (HP:0004431) | 5.19822161 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.04829951 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.01211751 |
| 10 | Febrile seizures (HP:0002373) | 4.84154639 |
| 11 | Focal motor seizures (HP:0011153) | 4.65487212 |
| 12 | Epidermoid cyst (HP:0200040) | 4.61131065 |
| 13 | Joint hemorrhage (HP:0005261) | 4.29307455 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 4.10221170 |
| 15 | Hyperventilation (HP:0002883) | 4.02623006 |
| 16 | Action tremor (HP:0002345) | 3.98162483 |
| 17 | Ketosis (HP:0001946) | 3.93893121 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.92191391 |
| 19 | Atonic seizures (HP:0010819) | 3.89612166 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79909496 |
| 21 | Abnormality of complement system (HP:0005339) | 3.78006478 |
| 22 | Hyperammonemia (HP:0001987) | 3.77667178 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.72426592 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.71965160 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.69721526 |
| 26 | Focal seizures (HP:0007359) | 3.68892224 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66497417 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47453402 |
| 29 | Myocardial infarction (HP:0001658) | 3.44270802 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.42643009 |
| 31 | Hyperglycinemia (HP:0002154) | 3.41215632 |
| 32 | Fat malabsorption (HP:0002630) | 3.35912287 |
| 33 | Myokymia (HP:0002411) | 3.35597315 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.33579296 |
| 35 | Polyphagia (HP:0002591) | 3.30512295 |
| 36 | Absent speech (HP:0001344) | 3.28500230 |
| 37 | Broad-based gait (HP:0002136) | 3.25536743 |
| 38 | Dysdiadochokinesis (HP:0002075) | 3.23632215 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 3.21906414 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17402826 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 3.10497326 |
| 42 | Ketoacidosis (HP:0001993) | 3.10443746 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09742764 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07964922 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.07964922 |
| 46 | Abnormality of methionine metabolism (HP:0010901) | 3.07395835 |
| 47 | Hyperglycinuria (HP:0003108) | 3.06869977 |
| 48 | Agitation (HP:0000713) | 3.00004538 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.95703369 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.90179186 |
| 51 | Hemiparesis (HP:0001269) | 2.90154470 |
| 52 | Mitral stenosis (HP:0001718) | 2.88614222 |
| 53 | Glomerulonephritis (HP:0000099) | 2.88342347 |
| 54 | Dialeptic seizures (HP:0011146) | 2.81892153 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80159962 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.79583779 |
| 57 | Skin nodule (HP:0200036) | 2.78003804 |
| 58 | Intention tremor (HP:0002080) | 2.76572357 |
| 59 | Absence seizures (HP:0002121) | 2.74318157 |
| 60 | Cortical dysplasia (HP:0002539) | 2.69287913 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.69241921 |
| 62 | Drooling (HP:0002307) | 2.68564707 |
| 63 | Mutism (HP:0002300) | 2.64928417 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.64810176 |
| 65 | Hemiplegia (HP:0002301) | 2.62259321 |
| 66 | Excessive salivation (HP:0003781) | 2.60527876 |
| 67 | Limb dystonia (HP:0002451) | 2.59171693 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.58065407 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.56000526 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55571078 |
| 71 | Postural instability (HP:0002172) | 2.55548112 |
| 72 | Truncal ataxia (HP:0002078) | 2.54584536 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.53766654 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.52040314 |
| 75 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.51883923 |
| 76 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.51883923 |
| 77 | Genetic anticipation (HP:0003743) | 2.49057344 |
| 78 | Spastic diplegia (HP:0001264) | 2.48386217 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.44983518 |
| 80 | Back pain (HP:0003418) | 2.43490975 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.43276636 |
| 82 | Diplopia (HP:0000651) | 2.43074821 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.43074821 |
| 84 | Steatorrhea (HP:0002570) | 2.41265614 |
| 85 | Ankle clonus (HP:0011448) | 2.40084460 |
| 86 | Scanning speech (HP:0002168) | 2.39281134 |
| 87 | Vascular calcification (HP:0004934) | 2.38604119 |
| 88 | Esophageal varix (HP:0002040) | 2.37462492 |
| 89 | Abnormal eating behavior (HP:0100738) | 2.33720356 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 2.33670711 |
| 91 | Gout (HP:0001997) | 2.33092270 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31744682 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29000451 |
| 94 | Generalized tonic-clonic seizures (HP:0002069) | 2.28632436 |
| 95 | Widely spaced teeth (HP:0000687) | 2.24009331 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.23805745 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23101973 |
| 98 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20818351 |
| 99 | Lymphangioma (HP:0100764) | 2.20467206 |
| 100 | Nephritis (HP:0000123) | 2.16183226 |
| 101 | Lissencephaly (HP:0001339) | 2.14726206 |
| 102 | Hemorrhage of the eye (HP:0011885) | 2.12774453 |
| 103 | Irritability (HP:0000737) | 2.12541159 |
| 104 | Spastic tetraplegia (HP:0002510) | 2.11339366 |
| 105 | Postural tremor (HP:0002174) | 2.11257960 |
| 106 | Pachygyria (HP:0001302) | 2.09979225 |
| 107 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.09627927 |
| 108 | Spontaneous abortion (HP:0005268) | 2.09549792 |
| 109 | Medial flaring of the eyebrow (HP:0010747) | 2.08917024 |
| 110 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.08911448 |
| 111 | Hepatoblastoma (HP:0002884) | 2.06960119 |
| 112 | Impaired smooth pursuit (HP:0007772) | 2.06077270 |
| 113 | Inability to walk (HP:0002540) | 2.05369999 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.04366992 |
| 115 | Gait imbalance (HP:0002141) | 2.03640885 |
| 116 | Spastic gait (HP:0002064) | 2.02313698 |
| 117 | Esotropia (HP:0000565) | 2.01174359 |
| 118 | Turricephaly (HP:0000262) | 2.00952585 |
| 119 | Amyloidosis (HP:0011034) | 2.00939357 |
| 120 | Gingival bleeding (HP:0000225) | 2.00231561 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.00164963 |
| 122 | Pseudobulbar signs (HP:0002200) | 1.99986257 |
| 123 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.98545547 |
| 124 | Status epilepticus (HP:0002133) | 1.98314180 |
| 125 | Fair hair (HP:0002286) | 1.97459773 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97299707 |
| 127 | Urinary urgency (HP:0000012) | 1.96022710 |
| 128 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.95278433 |
| 129 | Supranuclear gaze palsy (HP:0000605) | 1.94161263 |
| 130 | Neonatal onset (HP:0003623) | 1.94007048 |
| 131 | Metabolic acidosis (HP:0001942) | 1.92321108 |
| 132 | Late onset (HP:0003584) | 1.91629219 |
| 133 | Dysmetria (HP:0001310) | 1.91418887 |
| 134 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91358043 |
| 135 | Cholelithiasis (HP:0001081) | 1.90247839 |
| 136 | Hyperglycemia (HP:0003074) | 1.88065892 |
| 137 | Abnormality of serum amino acid levels (HP:0003112) | 1.88062839 |
| 138 | Upper motor neuron abnormality (HP:0002127) | 1.87912149 |
| 139 | Ulnar claw (HP:0001178) | 1.86718932 |
| 140 | Sleep apnea (HP:0010535) | 1.85800350 |
| 141 | Blue irides (HP:0000635) | 1.85628830 |
| 142 | Congenital stationary night blindness (HP:0007642) | 1.83914899 |
| 143 | Glomerulosclerosis (HP:0000096) | 1.82730996 |
| 144 | Abnormality of the corticospinal tract (HP:0002492) | 1.82187382 |
| 145 | Hypothermia (HP:0002045) | 1.80864917 |
| 146 | Purpura (HP:0000979) | 1.80040850 |
| 147 | Protruding tongue (HP:0010808) | 1.77911587 |
| 148 | Sensorimotor neuropathy (HP:0007141) | 1.77591467 |
| 149 | Intellectual disability, progressive (HP:0006887) | 1.77285267 |
| 150 | Acanthocytosis (HP:0001927) | 1.76697122 |
| 151 | Arthropathy (HP:0003040) | 1.76691026 |
| 152 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76565519 |
| 153 | Polycythemia (HP:0001901) | 1.75903505 |
| 154 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75872158 |
| 155 | Hydroxyprolinuria (HP:0003080) | 1.75644494 |
| 156 | Abnormality of proline metabolism (HP:0010907) | 1.75644494 |
| 157 | Menorrhagia (HP:0000132) | 1.75338099 |
| 158 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75165540 |
| 159 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.74820167 |
| 160 | Global brain atrophy (HP:0002283) | 1.74541422 |
| 161 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.74248065 |
| 162 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.74248065 |
| 163 | Hypophosphatemic rickets (HP:0004912) | 1.74206032 |
| 164 | Polydipsia (HP:0001959) | 1.74176861 |
| 165 | Abnormal drinking behavior (HP:0030082) | 1.74176861 |
| 166 | Death in childhood (HP:0003819) | 1.73962075 |
| 167 | Rickets (HP:0002748) | 1.73950308 |
| 168 | Lower limb muscle weakness (HP:0007340) | 1.73148224 |
| 169 | Thrombophlebitis (HP:0004418) | 1.72729384 |
| 170 | Syncope (HP:0001279) | 1.72276288 |
| 171 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72272518 |
| 172 | Increased circulating renin level (HP:0000848) | 1.72123716 |
| 173 | Symptomatic seizures (HP:0011145) | 1.70615440 |
| 174 | Generalized hypopigmentation of hair (HP:0011358) | 1.69175234 |
| 175 | Exotropia (HP:0000577) | 1.69140085 |
| 176 | Enlarged kidneys (HP:0000105) | 1.68795620 |
| 177 | Intellectual disability, severe (HP:0010864) | 1.68572357 |
| 178 | Progressive inability to walk (HP:0002505) | 1.67559940 |
| 179 | Abnormality of midbrain morphology (HP:0002418) | 1.65208505 |
| 180 | Molar tooth sign on MRI (HP:0002419) | 1.65208505 |
| 181 | Hip dysplasia (HP:0001385) | 1.64976068 |
| 182 | Fetal akinesia sequence (HP:0001989) | 1.64624888 |
| 183 | Ventricular fibrillation (HP:0001663) | 1.64010676 |
| 184 | Impaired vibratory sensation (HP:0002495) | 1.63864639 |
| 185 | Peripheral demyelination (HP:0011096) | 1.61000669 |
| 186 | Stroke (HP:0001297) | 1.60259798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.65105476 |
| 2 | CASK | 3.51085619 |
| 3 | SIK1 | 3.16273033 |
| 4 | ERN1 | 3.14375395 |
| 5 | FGFR4 | 2.93403944 |
| 6 | MAP3K10 | 2.48886567 |
| 7 | FGFR2 | 2.37102247 |
| 8 | BCKDK | 2.36583615 |
| 9 | CAMK1D | 2.35789232 |
| 10 | CAMK1G | 2.34678471 |
| 11 | NTRK3 | 2.32209273 |
| 12 | INSRR | 2.19630395 |
| 13 | TRIB3 | 2.14158543 |
| 14 | PINK1 | 1.95396654 |
| 15 | PTK6 | 1.91508067 |
| 16 | ERBB4 | 1.90986669 |
| 17 | PKN2 | 1.74111404 |
| 18 | EPHB1 | 1.73367071 |
| 19 | MAP2K7 | 1.72517084 |
| 20 | TAOK3 | 1.65196713 |
| 21 | MAP2K4 | 1.56360377 |
| 22 | RIPK1 | 1.40378870 |
| 23 | SIK2 | 1.35017994 |
| 24 | MAP3K9 | 1.32680412 |
| 25 | TRIM28 | 1.30821009 |
| 26 | DYRK1B | 1.30451054 |
| 27 | FES | 1.23561103 |
| 28 | AKT3 | 1.23114804 |
| 29 | NTRK2 | 1.22363682 |
| 30 | LATS1 | 1.21819941 |
| 31 | DYRK2 | 1.21011754 |
| 32 | MAP4K2 | 1.20469295 |
| 33 | CDK6 | 1.14177574 |
| 34 | PKN1 | 1.13996883 |
| 35 | PRKCG | 1.13605738 |
| 36 | DAPK2 | 1.12590857 |
| 37 | TAOK1 | 1.12360892 |
| 38 | BCR | 1.12233335 |
| 39 | MINK1 | 1.11918694 |
| 40 | FGFR3 | 1.09886609 |
| 41 | CAMKK2 | 1.09481024 |
| 42 | SGK3 | 1.07301130 |
| 43 | PRKCZ | 1.07288498 |
| 44 | CDK12 | 1.04978691 |
| 45 | RET | 1.04529917 |
| 46 | FRK | 1.03623109 |
| 47 | CDK5 | 1.02740563 |
| 48 | PTK2B | 1.01801410 |
| 49 | PDGFRA | 1.01616931 |
| 50 | ERBB2 | 0.97880120 |
| 51 | MAPK11 | 0.97316601 |
| 52 | MAP3K7 | 0.97308802 |
| 53 | MAPK15 | 0.97135707 |
| 54 | EPHA4 | 0.96352359 |
| 55 | PHKG2 | 0.96171026 |
| 56 | PHKG1 | 0.96171026 |
| 57 | MAPK12 | 0.95919526 |
| 58 | GSK3A | 0.95628624 |
| 59 | EPHB2 | 0.95413722 |
| 60 | ICK | 0.95283544 |
| 61 | WNK3 | 0.95142882 |
| 62 | SIK3 | 0.92994264 |
| 63 | PAK6 | 0.91979063 |
| 64 | MAP3K4 | 0.91882192 |
| 65 | TNK2 | 0.90455633 |
| 66 | MTOR | 0.88784905 |
| 67 | TYK2 | 0.88657823 |
| 68 | JAK2 | 0.88087754 |
| 69 | SGK494 | 0.87790985 |
| 70 | SGK223 | 0.87790985 |
| 71 | BLK | 0.87204474 |
| 72 | CSNK1G2 | 0.86408561 |
| 73 | GRK6 | 0.85581849 |
| 74 | PRKAA2 | 0.84347750 |
| 75 | PRKCH | 0.83734985 |
| 76 | GRK5 | 0.83029882 |
| 77 | CSNK1A1L | 0.82411678 |
| 78 | ADRBK2 | 0.81778733 |
| 79 | PRKAA1 | 0.81150674 |
| 80 | CAMK2A | 0.81117667 |
| 81 | TYRO3 | 0.80275316 |
| 82 | TNIK | 0.79900751 |
| 83 | RIPK4 | 0.77742984 |
| 84 | SGK1 | 0.77228829 |
| 85 | PRKCE | 0.76905089 |
| 86 | PAK3 | 0.75447969 |
| 87 | TGFBR2 | 0.75045948 |
| 88 | SGK2 | 0.75024289 |
| 89 | FER | 0.74177226 |
| 90 | CSNK1G1 | 0.73879828 |
| 91 | PTK2 | 0.72660491 |
| 92 | PLK2 | 0.71626961 |
| 93 | FGR | 0.71445070 |
| 94 | PRKD1 | 0.71410957 |
| 95 | TIE1 | 0.70214278 |
| 96 | MAP3K12 | 0.69969143 |
| 97 | CSNK1G3 | 0.69174058 |
| 98 | MAP3K2 | 0.69161484 |
| 99 | GRK1 | 0.68611905 |
| 100 | BRD4 | 0.68270686 |
| 101 | PRKG1 | 0.68144793 |
| 102 | MATK | 0.67002264 |
| 103 | MAPK4 | 0.66584343 |
| 104 | CAMKK1 | 0.66437838 |
| 105 | LATS2 | 0.65191760 |
| 106 | EGFR | 0.64692703 |
| 107 | MAP3K11 | 0.64353315 |
| 108 | CAMK2B | 0.64195237 |
| 109 | CSK | 0.63936002 |
| 110 | EPHA3 | 0.62889611 |
| 111 | SYK | 0.62721376 |
| 112 | CAMK4 | 0.62556547 |
| 113 | PDGFRB | 0.62073911 |
| 114 | PRKACG | 0.61694368 |
| 115 | JAK1 | 0.60596005 |
| 116 | UHMK1 | 0.58925225 |
| 117 | DYRK1A | 0.58776493 |
| 118 | MAPK7 | 0.57213571 |
| 119 | BMX | 0.55516750 |
| 120 | TXK | 0.55505181 |
| 121 | PRKACA | 0.53975058 |
| 122 | ABL2 | 0.53804922 |
| 123 | RPS6KA2 | 0.53576612 |
| 124 | CSF1R | 0.52188720 |
| 125 | PDK1 | 0.49153512 |
| 126 | GRK7 | 0.45842096 |
| 127 | YES1 | 0.43404457 |
| 128 | MAPK13 | 0.43177482 |
| 129 | MAP2K1 | 0.42600954 |
| 130 | IRAK4 | 0.42475885 |
| 131 | NTRK1 | 0.42396597 |
| 132 | MAP4K1 | 0.42003707 |
| 133 | HIPK2 | 0.41451230 |
| 134 | STK11 | 0.41030107 |
| 135 | STK38 | 0.40903884 |
| 136 | ABL1 | 0.40854159 |
| 137 | MARK3 | 0.40730026 |
| 138 | WNK1 | 0.40410770 |
| 139 | MARK2 | 0.39736092 |
| 140 | MET | 0.39705423 |
| 141 | MAP3K1 | 0.39520710 |
| 142 | MAP2K6 | 0.39300961 |
| 143 | PRKCQ | 0.39136634 |
| 144 | WNK4 | 0.38734871 |
| 145 | RPS6KA3 | 0.38490953 |
| 146 | HCK | 0.38053234 |
| 147 | * CSNK1D | 0.37960111 |
| 148 | ERBB3 | 0.37801861 |
| 149 | FYN | 0.36896544 |
| 150 | KSR1 | 0.35424754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25996567 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.98079909 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53655433 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24700980 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07379270 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.82583700 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81822547 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77776971 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71252775 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41863113 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28880899 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24150436 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22813816 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15486953 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13176610 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.11298319 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10981602 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.95383988 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95045959 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93792668 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.92108619 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88666530 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88230003 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80348485 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.79210577 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78454879 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75644393 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70972373 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70971308 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.69547592 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68998718 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67130115 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.62607346 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57262664 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55830124 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50502022 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50202556 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47890589 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46158965 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.45560799 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45295978 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44254337 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38258593 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36372271 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 1.34694384 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34055328 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.33984746 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.32736402 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31177459 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.30021982 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29005414 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26593316 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25757492 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.22342655 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20620331 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20251562 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17883802 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12903259 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 1.10562412 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10533079 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09211815 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07525629 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07101238 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03690791 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01607501 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01433053 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00903573 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98541315 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96214990 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94938427 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94388762 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93419610 |
| 73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92317252 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90886228 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84975359 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82968042 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.78793855 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78171879 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78158054 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.77879092 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77027242 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76469816 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76448992 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74947830 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73730340 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72859886 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72059728 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69886758 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68399818 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68055698 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66760569 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65456140 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65419484 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65321607 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64407235 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.61993090 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61865646 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60273135 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.59900242 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59669312 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57104166 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56850797 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.55751275 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55578157 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54295240 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.53204516 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52970392 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52697573 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51061666 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50651104 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50523697 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48340152 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48041486 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46729646 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44420776 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44210042 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43283215 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42441115 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42287030 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41791259 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.41356689 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41099750 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39707902 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35617049 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35544261 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35475814 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34530452 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33989978 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33490697 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29692353 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28058305 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25482158 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24999069 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21226154 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18583682 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16611423 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12907901 |
| 138 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.12645958 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.11819085 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11433885 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10627245 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10534846 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.09577450 |
| 144 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08668150 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08463546 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08208930 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07273830 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.07263859 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.06611329 |
| 150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06221029 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.05940369 |
| 152 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05608535 |
| 153 | GABAergic synapse_Homo sapiens_hsa04727 | 0.04323478 |
| 154 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.04046353 |
| 155 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.03668468 |
| 156 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.02664708 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02273301 |
| 158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02177730 |
| 159 | Lysosome_Homo sapiens_hsa04142 | 0.01477702 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0155934 |
| 161 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0118673 |
| 162 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0028120 |

